Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation

Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation

Background: The impact of ticagrelor-based dual antiplatelet therapy (DAPT) on acute coronary syndrome (ACS) in patients with chronic kidney disease (CKD) remains unclear.Methods: Data on a total of 1,067 ACS patients with CKD including end-stage renal disease (ESRD) who underwent new-generation dru...

Full description

Bibliographic Details
Main Authors: Ji Woong Roh, Seung-Jun Lee, Byeong-Keuk Kim, Sung-Jin Hong, Hee-Yeol Kim, Chul-Min Ahn, Deok-Kyu Cho, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
ticagrelor
clopidogrel
acute coronary syndrome
renal insufficiency
drug eluting stents
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.707722/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.707722/full

Similar Items